Lung tumor motion change during stereotactic body radiotherapy (SBRT): an evaluation using MRI
- PMID: 24892328
- PMCID: PMC5711053
- DOI: 10.1120/jacmp.v15i3.4434
Lung tumor motion change during stereotactic body radiotherapy (SBRT): an evaluation using MRI
Abstract
The purpose of this study is to investigate changes in lung tumor internal target volume during stereotactic body radiotherapy treatment (SBRT) using magnetic resonance imaging (MRI). Ten lung cancer patients (13 tumors) undergoing SBRT (48 Gy over four consecutive days) were evaluated. Each patient underwent three lung MRI evaluations: before SBRT (MRI-1), after fraction 3 of SBRT (MRI-3), and three months after completion of SBRT (MRI-3m). Each MRI consisted of T1-weighted images in axial plane through the entire lung. A cone-beam CT (CBCT) was taken before each fraction. On MRI and CBCT taken before fractions 1 and 3, gross tumor volume (GTV) was contoured and differences between the two volumes were compared. Median tumor size on CBCT before fractions1 (CBCT-1) and 3 (CBCT-3) was 8.68 and 11.10 cm3, respectively. In 12 tumors, the GTV was larger on CBCT-3 compared to CBCT-1 (median enlargement, 1.56 cm3). Median tumor size on MRI-1, MRI-3, and MRI-3m was 7.91, 11.60, and 3.33 cm3, respectively. In all patients, the GTV was larger on MRI-3 compared to MRI-1 (median enlargement, 1.54 cm3). In all patients, GTV was smaller on MRI-3m compared to MRI-1 (median shrinkage, 5.44 cm3). On CBCT and MRI, all patients showed enlargement of the GTV during the treatment week of SBRT, except for one patient who showed minimal shrinkage (0.86 cm3). Changes in tumor volume are unpredictable; therefore, motion and breathing must be taken into account during treatment planning, and image-guided methods should be used, when treating with large fraction sizes.
Figures



Similar articles
-
Variations of target volume definition and daily target volume localization in stereotactic body radiotherapy for early-stage non-small cell lung cancer patients under abdominal compression.Med Dosim. 2017 Summer;42(2):116-121. doi: 10.1016/j.meddos.2017.01.008. Epub 2017 Apr 19. Med Dosim. 2017. PMID: 28433482 Clinical Trial.
-
Tumor motion changes in stereotactic body radiotherapy for liver tumors: an evaluation based on four-dimensional cone-beam computed tomography and fiducial markers.Radiat Oncol. 2017 Mar 23;12(1):61. doi: 10.1186/s13014-017-0799-7. Radiat Oncol. 2017. PMID: 28335794 Free PMC article.
-
Gross tumour volume variations in primary non-small-cell lung cancer during the course of treatment with stereotactic body radiation therapy.J Med Imaging Radiat Oncol. 2014;58(3):384-91. doi: 10.1111/1754-9485.12168. Epub 2014 Mar 5. J Med Imaging Radiat Oncol. 2014. PMID: 24592817 Clinical Trial.
-
MRI-guided lung SBRT: Present and future developments.Phys Med. 2017 Dec;44:139-149. doi: 10.1016/j.ejmp.2017.02.003. Epub 2017 Feb 24. Phys Med. 2017. PMID: 28242140 Review.
-
The impact of technology on the changing practice of lung SBRT.Phys Med. 2018 Mar;47:129-138. doi: 10.1016/j.ejmp.2017.12.020. Epub 2018 Jan 10. Phys Med. 2018. PMID: 29331227 Free PMC article. Review.
Cited by
-
Clinical evaluation of 4D MRI in the delineation of gross and internal tumor volumes in comparison with 4DCT.J Appl Clin Med Phys. 2019 Sep;20(9):51-60. doi: 10.1002/acm2.12699. J Appl Clin Med Phys. 2019. PMID: 31538719 Free PMC article.
-
Long-term stability assessment of a 4D tumor tracking system integrated into a gimbaled linear accelerator.J Appl Clin Med Phys. 2015 Sep 8;16(5):373–380. doi: 10.1120/jacmp.v16i5.5679. J Appl Clin Med Phys. 2015. PMID: 26699328 Free PMC article.
-
Comparative analysis of delivered and planned doses in target volumes for lung stereotactic ablative radiotherapy.Radiat Oncol. 2024 Aug 16;19(1):110. doi: 10.1186/s13014-024-02505-7. Radiat Oncol. 2024. PMID: 39152502 Free PMC article.
-
Target Localization Accuracy of Image Registrations in Cone Beam Computed Tomography-Guided Stereotactic Body Radiation Therapy for Lung Cancer.Thorac Cancer. 2025 Aug;16(15):e70147. doi: 10.1111/1759-7714.70147. Thorac Cancer. 2025. PMID: 40790840 Free PMC article.
References
-
- Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol. 2007;25(8):947–52. - PubMed
-
- Zhang J, Yang F, Li B, et al. Which is the optimal biologically effective dose of stereotactic body radiotherapy for Stage I non‐small‐cell lung cancer? A meta‐analysis. Int J Radiat Oncol Biol Phys. 2011;81(4):e305–e316. - PubMed
-
- Yeung AR, Li JG, Shi W, et al. Tumor localization using cone‐beam CT reduces setup margins in conventionally fractionated radiotherapy for lung tumors. Int J Radiat Oncol Biol Phys. 2009;74(4):1100–07. - PubMed
-
- Seppenwoolde Y, Shirato H, Kitamura K, et al. Precise and real‐time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys. 2002;53(4):822–34. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical